Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Genetics · Welander Distal Myopathy

Genetics and Family Risk

At a Glance

Welander Distal Myopathy (WDM) is an autosomal dominant genetic condition caused by a specific mutation in the TIA1 gene. An affected parent has a 50% chance of passing the mutation to each child. A genetic counselor can help families navigate predictive testing and understand their specific risks.

Welander Distal Myopathy (WDM) is an autosomal dominant condition, which means it can be passed down from a single parent to their children [1][2]. Navigating the genetics of WDM involves understanding your specific mutation and learning how to discuss these risks with your family.

The TIA1 Gene and Other Conditions

The TIA1 gene is active in many parts of the body. While the specific mutation that causes classic WDM (the E384K variant) primarily results in slowly progressive muscle weakness in the hands and feet, other mutations within the same TIA1 gene have been linked to different conditions, such as Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) [3][4].

Because these conditions share the same genetic “neighborhood” (the TIA1 gene), doctors classify them all under the umbrella of multisystem proteinopathies (MSP) [3]. However, it is deeply reassuring to know that if your family carries the classic WDM mutation, the expected outcome is the slow, distal muscle weakness characteristic of WDM, not these more rapid neurodegenerative diseases [3][1].

Rare Genetic Overlaps (Digenic Inheritance)

In exceptionally rare cases, a person might inherit the WDM mutation along with a second, separate genetic variant in a completely different gene (such as SQSTM1 or MYH7). This is known as digenic inheritance [5][6].

In these isolated cases, the combination of two different mutations can lead to additional symptoms, such as breathing or heart issues [7][6]. Your doctor or genetic counselor can tell you if your specific genetic report shows any of these exceptionally rare modifiers, but they do not reflect the standard journey for the vast majority of people with WDM.

Family Planning and Risk

Because WDM is autosomal dominant, there is a 50% chance of passing the mutation to each child [3][2].

  1. Transmission Risk: Each child of an affected parent has a 1-in-2 chance of inheriting the mutation.
  2. What to Expect: If a child inherits the mutation, they are expected to develop the same slowly progressive WDM as their parent, typically later in life (in their 40s or 50s) [3][1].
  3. Predictive Testing: Because symptoms do not appear until adulthood, children and young adults generally do not need to be tested. A genetic counselor can discuss whether predictive testing is appropriate for adult children who do not yet have symptoms, weighing the psychological impact against the benefits of knowing [3].

Working with a Genetic Counselor

A genetic counselor is an invaluable part of your care team. They can help your family navigate these risks, explain the latest research, and discuss options for family planning in a supportive, evidence-based environment [3]. They can also help you find patient advocacy groups or rare disease communities, which can be highly beneficial since WDM is strongly tied to specific geographic ancestries (Swedish/Finnish) [1][3].

Common questions in this guide

What is the chance of passing Welander Distal Myopathy to my children?
Because WDM is an autosomal dominant condition, there is a 50 percent chance of passing the TIA1 genetic mutation to each child. If a child inherits this mutation, they are expected to develop the same slowly progressive muscle weakness as their affected parent.
Will the TIA1 gene mutation for WDM cause ALS or dementia?
No. While other mutations in the TIA1 gene can cause diseases like ALS or Frontotemporal Dementia, the specific mutation for classic WDM typically only causes slow, progressive muscle weakness in the hands and feet.
Should my adult children get tested for the WDM mutation even if they have no symptoms?
Since WDM symptoms usually do not appear until a person is in their 40s or 50s, children and young adults generally do not need predictive testing. A genetic counselor can help adult children decide if testing is right for them before symptoms start by weighing the pros and cons.
What does digenic inheritance mean in WDM?
In exceptionally rare cases, a person might inherit the WDM mutation along with a second mutation in a completely different gene, such as SQSTM1 or MYH7. This rare combination can lead to additional symptoms like breathing or heart issues, but it is not the standard journey for most people.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should my siblings or adult children be tested for the TIA1 mutation even if they don't have any muscle weakness right now?
  2. 2.Does my genetic report show any 'digenic' markers like SQSTM1 or MYH7 variants, or do I just have the isolated TIA1 mutation?
  3. 3.Can you refer me to a genetic counselor who has experience with late-onset autosomal dominant muscle conditions?
  4. 4.What are the specific guidelines for predictive testing for my adult children, and what are the pros and cons of them knowing their status?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Does Welander Distal Myopathy Affect Heart & Breathing?Does Welander Distal Myopathy Cause ALS?Should My Child Be Tested for Welander Distal Myopathy?

References

References (7)
  1. 1

    A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy.

    Carrascoso I, Sánchez-Jiménez C, Silion E, et al.

    Molecular and cellular biology 2019; (39(1)) doi:10.1128/MCB.00299-18.

    PMID: 30348840
  2. 2

    Whole Exome Sequencing Identifies Atypical Welander Distal Myopathy in Patient.

    Gass J, Blackburn P, Jackson J, et al.

    Journal of clinical neuromuscular disease 2017; (18(3)):152-156 doi:10.1097/CND.0000000000000164.

    PMID: 28221306
  3. 3

    Diverse Phenotypic Presentation of the Welander Distal Myopathy Founder Mutation, With Myopathy and Amyotrophic Lateral Sclerosis in the Same Family.

    Purcell N, Manousakis G

    Journal of clinical neuromuscular disease 2024; (26(1)):42-46 doi:10.1097/CND.0000000000000501.

    PMID: 39163160
  4. 4

    Multisystem proteinopathy: Where myopathy and motor neuron disease converge.

    Korb MK, Kimonis VE, Mozaffar T

    Muscle & nerve 2021; (63(4)):442-454 doi:10.1002/mus.27097.

    PMID: 33145792
  5. 5

    Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients.

    Bermejo-Guerrero L, de Fuenmayor Fernández-de la Hoz CP, González-Quereda L, et al.

    Neuromuscular disorders : NMD 2023; (33(12)):983-987 doi:10.1016/j.nmd.2023.10.016.

    PMID: 38016875
  6. 6

    Distal myopathy with coexisting heterozygous TIA1 and MYH7 Variants.

    Brand P, Dyck PJ, Liu J, et al.

    Neuromuscular disorders : NMD 2016; (26(8)):511-5.

    PMID: 27282841
  7. 7

    Myopathy With SQSTM1 and TIA1 Variants: Clinical and Pathological Features.

    Niu Z, Pontifex CS, Berini S, et al.

    Frontiers in neurology 2018; (9()):147 doi:10.3389/fneur.2018.00147.

    PMID: 29599744

This page provides educational information about the genetics and family risk of Welander Distal Myopathy. It is not a substitute for professional medical advice or genetic counseling. Always consult a genetic counselor or healthcare provider for your specific situation.

Get notified when new evidence is published on Distal myopathy, Welander type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.